BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AviaraDx, Inc. Announces Appointment Of Mary Barry To Vice President Of Laboratory Operations


7/26/2006 11:09:49 AM

CARLSBAD, Calif., July 26 /PRNewswire/ -- AviaraDx, Inc., a molecular cancer profiling company enabling personalized medicine in oncology, announced today that Mary Barry, MT (ASCP), has joined the company as Vice President of Clinical Laboratory Operations.

"We are pleased that Mary has joined AviaraDx. She will lead the team setting up our diagnostic laboratory operations, which we expect to receive CLIA certification early in 2007," said Antonius Schuh, Ph.D., Chief Executive Officer of AviaraDx, Inc.

Ms. Barry joins AviaraDx with over 25 years of experience in clinical laboratory operations. Prior to joining us, Ms. Barry most recently served as the Vice President of Laboratory Operations for Prometheus Laboratories, Inc., where she oversaw the laboratory from inception through growth to over $50 Million in annual sales. Prior to Prometheus, Ms. Barry held senior positions with a high volume plasma screening laboratory operated by Bayer Pharmaceuticals, with the Immunogenetics Department of the UCSD Medical Center, and with the Molecular Biology and Immunochemistry Department reference laboratory of The Scripps Research Institute. Ms. Barry has a BS in Zoology from Oregon State University and an MBA from San Diego State University.

About AviaraDx, Inc.

AviaraDx, Inc., is focused on developing and commercializing molecular diagnostic technologies for personalized medicine in cancer treatment. The company is targeting the oncology market with three first-in-class molecular cancer profiling technologies: Molecular Cancer Identification (MCID), Breast Cancer Profiling (BCP) and Drug Response Profiling (DRP). To date, AviaraDx has licensed its MCID and BCP technologies for specific clinical indications to Quest Diagnostics, Laboratory Corporation of America and Agendia BV. The Company also anticipates having its own CLIA-certified, specialty laboratory operations in early 2007 to complement its current partner offerings. AviaraDx, formerly Arcturus Bioscience, has recently relocated its headquarters from Mountain View, California, to Carlsbad, California. Please visit the AviaraDx website at http://www.aviaradx.com for more information.

Contact: Steve Zaniboni Chief Financial Officer (760) 579-0514

AviaraDx, Inc.

CONTACT: Steve Zaniboni, Chief Financial Officer of AviaraDx, Inc.,+1-760-579-0514



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES